IAS News and Literature Updates:
March and April 2019

From the President's Desk:

Raul Santos
I am very happy to inform our community that IAS has a new Board member: Zaneta Petrulioniene (First Department of Cardiology, Vilnius University, Hospital Santariškių Klinikos, Vilnius, Lithuania). Dear Zaneta, welcome among us!
I am pleased to announce that the International Atherosclerosis Society is launching the
Wael Al-Mahmeed & IAS Research Training Grants and Fellowships for the MENA Region project. The entire IAS Board is honored and grateful to announce that this high-level initiative has been made possible by a generous donation from Dr. Wael Abdulrahman Al Mahmeed (Abu Dhabi, UAE).
Read More

            IAS ACTIVITIES         

Please download the flyer and link for further information and application online.


IAS proudly announcing its collaboration with Fundación Hipercolesterolemia Familiar and Iberoamerican FH Newtwork Association.

The IAS and OSLA are happy to announce the 5th IAS-OSLA Course of the series on "LIpid Metabolism and Cardiovascular Risk" held in Muscat, Oman, on February 8-11, 2019 has been extremely successful. The series of residential courses aims to increase the knowledge and experience of early- to mid-career English-speaking clinicians practicing in the MENA region countries and interested in the management of lipid disorders.This unique series has also been successful in linking local, regional, and international leaders in the field of lipid management.
For more information on the 2019 residential IAS-OSLA Course please click here where you can find:


We are also pleased to announce that the International Atherosclerosis Society (IAS) and the Oman Society of Lipid & Atherosclerosis (OSLA) will organize the 6th IAS-OSLA Course on Lipid Metabolism and Cardiovascular Risk to be held in Muscat (Oman) in February 2020.


We are pleased to announce that:


IAS is pleased to endorse the 2019 HDL workshop being held in Valencia, Spain 25-27th September, 2019.

A full and exciting program has been developed by an international advisory board of HDL experts across the globe, and the meeting will also feature oral communications from abstract submissions, and a conference awards dinner.
This meeting, featuring world-renowned experts in all facets of HDL will bring you cutting edge updates across a wide variety of topics. Your all-inclusive registration includes all catering and a conference awards dinner. Visit https://hdl2019.yoursecretariat.com.au or click HERE to read more.
Abstract submission and registration open March 1st, 2019.


7th  IAS-Weill Cornell Seminar on Lipid Metabolism and Cardiovascular Risk, Salzburg, Austria, November 3-9, 2019.

The residential Seminar is directed to physicians practicing in Central and Eastern Europe, Central Asia, the former Soviet Union and other countries in transition. The Seminar is organized jointly by the IAS, Weill Cornel Medical College, and the American Austrian Foundation. For further information please link to http://www.aaf-online.org/

   NEWS from the IAS MEMBERS  

Iraqi Lipid Clinics Network
The success story deriving from the educational activities of the IAS and OSLA in the MENA Region continues. Thanks to the efforts of Dr. Mutaz Alkhnifsaw and his Iraqi collegagues at the moment 12 Lipid clinics have been established throughout the country.
Dr. Mutaz Al-khnifsawi, the President of the Iraqi Lipid Clinics Network was invited by the Federal Ministry of Health in Iraq to attend the first meeting between the Network and the Ministry to support the mission of improving health care for FH patients in Iraq and improve the quality of early diagnosis and treatment of this genetic disorder.
The Iraqi Lipid Clinics Network announced the launch of the Iraqi national pediatric FH screening program in collaboration with and under the auspices of the International Atherosclerosis Society in two cities in Iraq , Diwaniya and Al-Samawa) for early diagnosis and treatment of familial hypercholesterolemia in Iraq.

Dear colleagues
Good day!
I am very pleased to inform you that after a year of planning and preparations , the Iraqi lipid clinics network in collaboration with the federal ministry of health in Iraq , under sponsorship of Al-Mamorah scientific bureau,  on behalf of the international atherosclerosis society established the 12th lipid clinics in the city of Mosul 480 km to the northeast of the capital Baghdad. The activity included a symposium about FH for the medical staff in Ibn Sina teaching hospital in which the clinics will work.
Mosul is the second big Iraqi city after the Capital Baghdad in which more than 2 million people live. The clinic will provide health care for familial hypercholesterolemia patients there.
Thanks to the great support of the IAS.
Kindest regards
Mutaz . R. Al-khnifsawi
General cardiologist
EAS-FHSC national lead investigator
President of the Iraqi lipid clinics network
Member of the European society of cardiology
Member of the European hypertension society
Member of the European atherosclerosis society
Assistant lecturer of cardiology
Faculty of medicine -Al-Qadisiyah university- Iraq
Web site: www.dr-mutazclinic.com


The Lipid Working Group of the Kyrgyz Society of Cardiology has been substituted by the Kyrgyz Atherosclerosis Society.

Also included in this Newsletter:

Monday 27 May 11:00 - 12:15

IAS-EAS Joint Symposium

during the 87th EAS CONGRESS 2019
Maastricht, The Netherlands

In the News:
     Featured Commentaries    

Revisiting Reverse Cholesterol Transport in the Context of Free Cholesterol Bioavailability

By: Corina Rosales and Henry J. Pownall

Atherosclerotic cardiovascular disease (ACVD) is characterized by cholesterol accumulation within the subendothelial space of the arterial wall. Discovery of the reaction of lecithin:cholesterol acyltransferase (LCAT), which esterifies free cholesterol (FC), mainly on high density lipoprotein (HDL), provoked the hypothesis that LCAT is part of a broader cholesterol transport process that sequesters cholesterol as cholesteryl ester (CE) in HDL thereby preventing accumulation of cytotoxic FC levels in peripheral tissues, which cannot catabolize FC.

> View Complete Commentary <

Life-and-death decisions in cholesterol balance of the small intestine

By: Luke J. Engelking

In 1993, Brown and Goldstein identified Sterol Regulatory Element-binding Protein 2 (SREBP-2) as a transcription factor that activates cholesterol synthesis and low-density lipoprotein cholesterol (LDL-C) uptake. SREBP-2 was shown to increase the production of mRNAs encoding the LDL receptor and all the enzymes known to be required for cholesterol synthesis. SREBP-2 is produced in the endoplasmic reticulum (ER) as a membrane-bound transcription factor that is carried to the Golgi by an escort protein called Scap.

> View Complete Commentary <

   XIX International Symposium on Atherosclerosis 2021  


 Upcoming Meetings 

May 2-5, 2019


International Advanced Course on "Cardiovascular Prevention and Lipoprotein in Pediatrics"
Turin, Italy

View the Program

May 26-29, 2019


IAS-EAS Joint Symposium during the
87th EAS Congress

Maastricht, The Netherlands

View Meeting Website

July 4-6, 2019

12th Summer School of the Hellenic Atherosclerosis Society focused on Treatment of everyday patients with established cardiovascular disease or cardiometabolic risk factors: Interactive Discussion of Clinical Cases
Athens, Greece

View Website http://en.atherosclerosis.gr/


July 11-13, 2019


Symposium on Cardiology, Diabetes & Nephrology at the Limits

São Paulo, Brazil


Scientific Program of the Symposium
For more information please link to: https://www.atthelimits.org/cardiology-diabetes-nephrology/cdnb-2019

August 16-17, 2019


17th Brazilian Congress of Atherosclerosis
Campos do Jordão, São Paulo

View Meeting Website

For a complete listing of all Member Society Meetings and educational activities



The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Kaneka Europe, Kowa Company, Ltd., Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.
>> Back To Top <<
IAS Newsletter Editors
Website Editorial Board
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy

Emanuela Folco, PhD
Milan, Italy

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA

 Executive Director

Emanuela Folco, Ph.D.
International Atherosclerosis Society
Viale Piave 35 
20129 Milan, Italy 
Tel: +39 02 29006267
Fax: +39 02 29007018
E-mail: emanuela.folco@athero.org; info@athero.org

US Office:
International Atherosclerosis Society 
C/O SobelCo
50 Tice Boulevard, Suite 175
Woodcliff Lake, NJ 07677, USA
E-mail: info@athero.org

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129

Add us to your address book

Copyright (C) 2019 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile